Hatch-Waxman 2021 Year in Review

This webinar has ended.


The Hatch-Waxman Act, passed in 1984, revolutionized the generic drug industry, and its effects are still being felt today. Several cases decided in 2021, including those touching on induced infringement and venue, could have far-reaching effects on the practice.

Fish attorneys Geoff Biegler and Megan Chacon provide an overview of Hatch-Waxman litigation in 2021. Geoff and Megan discuss the following topics and more:

  • 2021 Hatch-Waxman litigation trends
  • Select court cases and appellate guidance
  • Outlook for 2022